1. Home
  2. DHY vs BTMD Comparison

DHY vs BTMD Comparison

Compare DHY & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DHY
  • BTMD
  • Stock Information
  • Founded
  • DHY 1998
  • BTMD 2012
  • Country
  • DHY United States
  • BTMD United States
  • Employees
  • DHY N/A
  • BTMD N/A
  • Industry
  • DHY Finance/Investors Services
  • BTMD Medicinal Chemicals and Botanical Products
  • Sector
  • DHY Finance
  • BTMD Health Care
  • Exchange
  • DHY Nasdaq
  • BTMD Nasdaq
  • Market Cap
  • DHY 211.3M
  • BTMD 129.1M
  • IPO Year
  • DHY N/A
  • BTMD N/A
  • Fundamental
  • Price
  • DHY $2.14
  • BTMD $4.08
  • Analyst Decision
  • DHY
  • BTMD Strong Buy
  • Analyst Count
  • DHY 0
  • BTMD 1
  • Target Price
  • DHY N/A
  • BTMD $8.00
  • AVG Volume (30 Days)
  • DHY 569.1K
  • BTMD 125.4K
  • Earning Date
  • DHY 01-01-0001
  • BTMD 08-07-2025
  • Dividend Yield
  • DHY 9.10%
  • BTMD N/A
  • EPS Growth
  • DHY N/A
  • BTMD 201.68
  • EPS
  • DHY N/A
  • BTMD 0.60
  • Revenue
  • DHY N/A
  • BTMD $199,379,000.00
  • Revenue This Year
  • DHY N/A
  • BTMD $5.87
  • Revenue Next Year
  • DHY N/A
  • BTMD $8.59
  • P/E Ratio
  • DHY N/A
  • BTMD $6.80
  • Revenue Growth
  • DHY N/A
  • BTMD 6.44
  • 52 Week Low
  • DHY $1.77
  • BTMD $3.04
  • 52 Week High
  • DHY $2.08
  • BTMD $8.44
  • Technical
  • Relative Strength Index (RSI)
  • DHY 60.85
  • BTMD 52.38
  • Support Level
  • DHY $2.12
  • BTMD $3.92
  • Resistance Level
  • DHY $2.00
  • BTMD $4.36
  • Average True Range (ATR)
  • DHY 0.02
  • BTMD 0.20
  • MACD
  • DHY 0.00
  • BTMD -0.01
  • Stochastic Oscillator
  • DHY 76.47
  • BTMD 36.00

About DHY Credit Suisse High Yield Bond Fund

Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Share on Social Networks: